Document is current
Any future updates will be listed below
-
Authors
Deverka, Patricia A.
Majumder, Mary A.
Villanueva, Angela G.
Anderson, Margaret
Bakker, Annette C.
Bardill, Jessica
Boerwinkle, Eric
Bubela, Tania
Evans, Barbara J.
Garrison, Nanibaa’ A.
Gibbs, Richard A.
Gentleman, Robert
Glazer, David
Goldstein, Melissa M.
Greely, Hank
Harris, Crane
Knoppers, Bartha M.
Koenig, Barbara A.
Kohane, Isaac S.
La Rosa, Salvatore
Mattison, John
O’Donnell, Christopher J.
Rai, Arti K.
Rehm, Heidi L.
Rodriguez, Laura L.
Shelton, Robert
Simoncelli, Tania
Terry, Sharon F.
Watson, Michael S.
Wilbanks, John
Cook-Deegan, Robert
McGuire, Amy L.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (R01HG008918, K01HG008818, P20HG007243, U54HG007963, U01HG006500)
National Human Genome Research Institute (U01HG006507)
National Human Genome Research Institute (U01HG007307-02S2)
National Patient-Centered Clinical Research Network (CC2-GA-2000-52)
Robert Wood Johnson Foundation's Health Data Exploration Project
- License Information
-
More Information
Article History
First Online: 22 September 2017
Competing interests
: Baylor College of Medicine (BCM) and Miraca Holdings, Inc. have formed a joint venture with shared ownership and governance of the Baylor Genetics Laboratories. All co-authors at BCM have no competing interests. MA was employed at FasterCures during the development of this manuscript and is currently employed by Deloitte. RG is employed by and a shareholder in 23andMe, plus is on the Scientific Advisory Board for the Bioconductor Project and Elixir (EU). DG is employed by Verily. CH is employed by Illumina, Inc. HLR is on the Scientific Advisory Board of Genome Medical, Inc. RS is the CEO of Private Access, Inc. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional.
